Chemotherapy of Breast Cancer

Abstract

To the Editor: The recent cautions that long-term adjuvant chemotherapy in resectable breast cancer be considered experimental rather than a confirmed treatment, expressed by Dr. Mary Costanza in "The Problem of Breast Cancer Prophylaxis" (N Engl J Med 293:1095–1098, 1975), is extraordinarily appropriate, but because of media publicity, her advice is not likely to be followed by physicians or by patients. I recently attended two large symposiums on breast cancer, and the attitude of immediate triumph, rather than considerate caution, was in the air. Both physicians and patients want the new treatment now. This fact is probably more of . . .